APOE and Alzheimer disease: A recent Mendelian randomization study on the risk factors for AD found that genetically elevated TC and LDL-C levels increased neurotic plaque burden, but the effects were driven by single nucleotide polymorphisms of APOE [28], whose genetic product is known to be the key ligand for remnant lipoprotein clearance by the liver.